Back

Randomized controlled trials of continued versus interrupted oral anti-coagulant at the time of device surgery: Combined analysis of BRUISE CONTROL 1 and 2

20 March 2018 (09:42 - 09:52)
Organised by:
Congress Presentation Part of: Late-Breaking Trials Device Complications and Lead Extraction EHRA Premium Access EHRA 2018

About the speaker

Photo
Professor Vidal Essebag

McGill University Health Centre, Montreal (Canada)

14 More presentations in this session

Presentation thumbnail
Thoracoscopic versus catheter ablation for atrial fibrillation: Long-term follow-up of the FAST randomised trial
Professor D. Kotecha (Birmingham, GB)
Slides Video
Presentation thumbnail
Discussant review - Thoracoscopic versus catheter ablation for atrial fibrillation: Long-term follow-up of the FAST randomised trial
Professor S. Benussi (Brescia, IT)
Slides Video
Presentation thumbnail
Panel discussion
Video
Presentation thumbnail
Surgical versus catheter ablation for paroxysmal and early persistent atrial fibrillation
Doctor A. Elvan (Braunschweig, DE)
Presentation thumbnail
Discussant review - Surgical versus catheter ablation for paroxysmal and early persistent atrial fibrillation
Professor J. Kautzner (Prague, CZ)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Trials

The Event

Event poster

EHRA 2018

20 March 2018 09:42 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources